4-(1-((tert-Butoxycarbonyl)amino)ethyl)benzoic acid, 95.0%, 250mg

4-(Bromomethyl)pyrimidine hydrobromide, 95.0%, 1g

(8R,9S,10S,13S,14S)-10,13-dimethyl-17-(pyridin-3-yl)-2,3,4,5,6,7,8,9,10,11,12,13,14,15-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate, 97%, 25mg

1-Boc-4-(6-Chloro-5-nitro-4-pyrimidinyl)piperazine, 95.0%, 250mg

N-butyl-N-methylpyrrolidinium bis((trifluoromethyl)sulfonyl)imide, 98.0%, 100g

8-nitro-1,4-dihydroquinazolin-4-one, 98%, 1g

Nile Blue Chloride�, 85.0%, 25g

Di-p-tolylphosphine oxide, 95.0%, 100g

Mikroliterspritze für HPLC, 50 µl, 1 Stück

Cyclopentanecarboxaldehyde (stabilized with HQ), 95.0%, 10g

4-Azidobenzoic acid, 95.0%, 5g

ethyl 1-[4-(trifluoromethyl)pyrimidin-2-yl]piperidine-4-carboxylate, 1g

1-(4-Fluorobenzyl)hydrazine dihydrochloride, 95.0%, 10g